Author:
van der Bijl Arie E.,Breedveld Ferdinand C.,Antoni Christian E.,Kalden Joachim R.,Kary Sonja,Burmester Gerd R.,Beckmann Christina,Unnebrink Kristina,Kupper Hartmut
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference29 articles.
1. Breedveld FC, Weisman MH, Kavanaugh AF et al (2006) The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54:26–37
2. Genovese MC, Bathon JM, Fleischmann RM et al (2005) Long-term safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis. J Rheumatol 32:1232–1242
3. Keystone EC, Kavanaugh AF, Sharp JT et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50:1400–1411
4. Navarro-Sarabia F, Ariza-Ariza R, Hernandez-Cruz B et al (2005) Adalimumab for treating rheumatoid arthritis. Cochrane Database Syst Rev 3:CD005113
5. Smolen JS, van der Heijde DM, St Clair EW et al (2006) Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 54:702–710
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献